1. Home
  2. RETO vs SABS Comparison

RETO vs SABS Comparison

Compare RETO & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RETO
    SELLHOLDBUYas of 8 hours ago
  • SABS
    SELLHOLDBUYas of 8 hours ago
  • Stock Information
  • Founded
  • RETO 1999
  • SABS 2014
  • Country
  • RETO China
  • SABS United States
  • Employees
  • RETO N/A
  • SABS N/A
  • Industry
  • RETO Multi-Sector Companies
  • SABS Biotechnology: Pharmaceutical Preparations
  • Sector
  • RETO Consumer Discretionary
  • SABS Health Care
  • Exchange
  • RETO Nasdaq
  • SABS Nasdaq
  • Market Cap
  • RETO 19.9M
  • SABS 19.0M
  • IPO Year
  • RETO 2017
  • SABS N/A
  • Fundamental
  • Price
  • RETO $3.44
  • SABS $1.15
  • Analyst Decision
  • RETO
  • SABS Strong Buy
  • Analyst Count
  • RETO 0
  • SABS 5
  • Target Price
  • RETO N/A
  • SABS $11.40
  • AVG Volume (30 Days)
  • RETO 53.0K
  • SABS 32.0K
  • Earning Date
  • RETO 10-28-2024
  • SABS 05-19-2025
  • Dividend Yield
  • RETO N/A
  • SABS N/A
  • EPS Growth
  • RETO N/A
  • SABS N/A
  • EPS
  • RETO N/A
  • SABS N/A
  • Revenue
  • RETO $3,841,142.00
  • SABS $1,322,410.00
  • Revenue This Year
  • RETO N/A
  • SABS N/A
  • Revenue Next Year
  • RETO N/A
  • SABS $25.00
  • P/E Ratio
  • RETO N/A
  • SABS N/A
  • Revenue Growth
  • RETO N/A
  • SABS N/A
  • 52 Week Low
  • RETO $0.33
  • SABS $1.00
  • 52 Week High
  • RETO $7.10
  • SABS $5.01
  • Technical
  • Relative Strength Index (RSI)
  • RETO 51.75
  • SABS 28.05
  • Support Level
  • RETO $3.43
  • SABS $1.00
  • Resistance Level
  • RETO $3.84
  • SABS $1.80
  • Average True Range (ATR)
  • RETO 0.51
  • SABS 0.14
  • MACD
  • RETO -0.19
  • SABS -0.02
  • Stochastic Oscillator
  • RETO 12.94
  • SABS 15.00

Stock Price Comparison Chart: RETO vs SABS

RETO
SABS
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April050100150200250300350RETO VS SABS

About RETO ReTo Eco-Solutions Inc.

ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly-ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation and construction of urban ecological environments for capturing, controlling and re-using rainwater. It operates through four segments namely Machinery and Equipment sales, Construction materials sales, Municipal Construction Projects, and Technology Consulting and other services. The company earns its revenue from Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use